ArticleBMJ open respiratory research2024

Extracorporeal photopheresis (ECP) in the treatment of chronic lung allograft dysfunction (CLAD): a prospective, multicentre, open-label, randomised controlled trial studying the addition of ECP to standard care in the treatment of bilateral lung transplant patients with CLAD (E-CLAD UK).

Andrew J Fisher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.